Oxford Vaccine Study Due; Merkel Hopeful on Pact: Virus Update

AstraZeneca Plc shares gained before results from an early clinical trial of the experimental vaccine it is developing with the University of Oxford. Britain agreed to buy 90 million doses of vaccines in development by drugmakers including Pfizer Inc., BioNTech SE and Valneva SE.